Cysteine induces mitochondrial reductive stress in glioblastoma through hydrogen peroxide production
Noch, E. K.; Palma, L.; Yim, I.; Barnett, D.; Walsh, A.; Bhinder, B.; Benedetti, E.; Krumsiek, J.; Gurvitch, J.; Khwaja, S.; Elemento, O.; Cantley, L.
Show abstract
Glucose and amino acid metabolism are critical for glioblastoma (GBM) growth, but little is known about the specific metabolic alterations in GBM that are targetable with FDA-approved compounds. To investigate tumor metabolism signatures unique to GBM, we interrogated The Cancer Genome Atlas for alterations in glucose and amino acid signatures in GBM relative to other human cancers and found that GBM exhibits the highest levels of cysteine and methionine pathway gene expression of 32 human cancers. Treatment of patient-derived GBM cells with the FDA-approved cysteine compound N-acetylcysteine (NAC) reduce GBM cell growth and mitochondrial oxygen consumption, which was worsened by glucose starvation. Mechanistic experiments revealed that cysteine compounds induce rapid mitochondrial H2O2 production and reductive stress in GBM cells, an effect blocked by oxidized glutathione, thioredoxin, and redox enzyme overexpression. These findings indicate that GBM is uniquely susceptible to NAC-driven reductive stress and could synergize with glucose-lowering treatments for GBM.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.